PolyNovo Gets Approval for Sales of NovoSorb BTM

  • Dec 13, 2019 AEDT
  • Team Kalkine

PolyNovo Limited (ASX: PNV), an Australian based medical company, has received approval to sell its NovoSorb BTM product throughout the European Union and UK/Ireland.

  • NovoSorb BTM is a dermal scaffold for the regeneration of dermis when lost through extensive surgery or burn;
  • The company’s shares were placed in a trading halt this morning before opening of the market.

At AEST 01:14PM, the stock was trading at $1.950 per share, up by 12.392% from its previous close.


All pictures are copyright to their respective owner(s).Kalkinemedia.com does not claim ownership of any of the pictures displayed on this website unless stated otherwise. Some of the images used on this website are taken from the web and are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it below the image.


There is no investor left unperturbed with the ongoing trade conflicts between US-China and the devastating bushfire in Australia.

Are you wondering if the year 2020 might not have taken the right start? Dividend stocks could be the answer to that question.

As interest rates in Australia are already at record low levels, find out which dividend stocks are viewed as the most attractive investment opportunity in the current scenario in our report.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK